0 followers
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.
Eddie J. Sullivan
Azurity Pharmaceuticals
4 followers
Xeris Pharmaceuticals
2 followers
Rancho BioSciences
2 followers
Catalyst Pharmaceuticals
2 followers
Crinetics Pharmaceuticals
1 follower
Providence Medical Technology
1 follower
CorMedix
1 follower
Leadiant Biosciences
1 follower
Sight Sciences
2 followers
OM1
2 followers
cGMP Validation LLC
1 follower
Explore companies